Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about McKesson Corporation
McKesson Corporation News
McKesson Corporation Quantitative Score
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
McKesson Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
McKesson Corporation Financials
Table Compare
Compare MCK metrics with: | |||
|---|---|---|---|
Earnings & Growth | MCK | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | MCK | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | MCK | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | MCK | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
McKesson Corporation Income
McKesson Corporation Balance Sheet
McKesson Corporation Cash Flow
McKesson Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
McKesson Corporation Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.9500 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-10-01 | 0.82 | Quarterly |
| 2025-07-01 | 0.71 | Quarterly |
| 2025-04-01 | 0.71 | Quarterly |
| 2025-01-02 | 0.71 | Quarterly |
| 2024-10-01 | 0.71 | Quarterly |
Historical Market Cap
Shares Outstanding
McKesson Corporation Executives
| Name | Role |
|---|---|
| Mr. Brian S. Tyler Ph.D. | Chief Executive Officer & Director |
| Mr. Britt J. Vitalone CPA | Executive Vice President & Chief Financial Officer |
| Ms. Michele Lau J.D. | Executive Vice President & Chief Legal Officer |
| Ms. LeAnn B. Smith | Executive Vice President & Chief Human Resources Officer |
| Mr. Thomas L. Rodgers M.B.A. | Executive Vice President and Chief Strategy & Business Development Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Brian S. Tyler Ph.D. | Chief Executive Officer & Director | Male | 1967 | 5.5M |
| Mr. Britt J. Vitalone CPA | Executive Vice President & Chief Financial Officer | Male | 1970 | 2.43M |
| Ms. Michele Lau J.D. | Executive Vice President & Chief Legal Officer | Female | 1976 | 1.95M |
| Ms. LeAnn B. Smith | Executive Vice President & Chief Human Resources Officer | Female | 1975 | 1.54M |
| Mr. Thomas L. Rodgers M.B.A. | Executive Vice President and Chief Strategy & Business Development Officer | Male | 1972 | 1.43M |
McKesson Corporation Insider Trades
| Date | 8 Aug |
| Name | Rutledge Napoleon B JR |
| Role | SVP, Controller & CAO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 329 |
| Date | 30 Jul |
| Name | Gerberding Julie L. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 301 |
| Date | 30 Jul |
| Name | OZAN KEVIN M |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 301 |
| Date | 30 Jul |
| Name | Doughtie Lynne M |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 301 |
| Date | 30 Jul |
| Name | Hinton James H. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 301 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 8 Aug | Rutledge Napoleon B JR | SVP, Controller & CAO | Disposed | S-Sale | 329 |
| 30 Jul | Gerberding Julie L. | Director | Acquired | A-Award | 301 |
| 30 Jul | OZAN KEVIN M | Director | Acquired | A-Award | 301 |
| 30 Jul | Doughtie Lynne M | Director | Acquired | A-Award | 301 |
| 30 Jul | Hinton James H. | Director | Acquired | A-Award | 301 |